Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/15 19:43 | 12/16/15 | VNDA | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | P | 100 | 8.97 | 6 | 11 | 0 | 5,997 | I | -14 | -27 | -27 | -33 | -5 | -5 | 15 | 9 | 3 | 3 | -6 | -16 | 19 | 70 |
12/18/15 19:40 | 12/10/15 | VNDA | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | P.am | 3,665 | 8.60 | 6 | 426 | 8 | 5,986 | I | -14 | -27 | -27 | -33 | -5 | -5 | 15 | 9 | 3 | 3 | -6 | -16 | 19 | 70 |
12/11/15 18:06 | 12/9/15 | VNDA | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | P.m | 10,063 | 8.38 | 5 | 1,201 | 18 | 8,043 | I | -12 | -32 | -33 | -35 | -22 | -9 | -11 | 3 | 0 | 9 | 6 | -9 | 25 | 85 |
12/24/14 14:06 | 12/23/14 | VNDA | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | P | 2,333 | 14.40 | 11 | 162 | 4 | 4,140 | I | 250 | 16 | -14 | 21 | 8 | 7 | 7 | 7 | 8 | 5 | -10 | -33 | -6 | -29 |
2/13/12 18:03 | 8/22/11 | VNDA | Health | Drug | Pharmaceutical Preparations | Polymeropoulos Mihael Hristos | MD | DO | P,CEO | P.am | 53 | 5.35 | 1 | 10 | 3 | 409 | D | -52 | -31 | -10 | -6 | 14 | 7 | 2 | -3 | -6 | -8 | -11 | -16 | -20 | -23 |
8/30/11 16:31 | 8/29/11 | VNDA | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | MD | O | SVP,CFO, | P | 30 | 5.99 | 1 | 5 | New | 5 | D | -57 | -5 | -19 | -20 | -16 | 0 | 11 | 12 | 0 | -7 | -16 | -21 | -24 | -27 |
8/24/11 16:29 | 8/22/11 | VNDA | Health | Drug | Pharmaceutical Preparations | Polymeropoulos Mihael Hristos | MD | DO | P,CEO | P.m | 53 | 5.35 | 1 | 10 | 3 | 390 | D | -60 | -14 | -24 | -24 | -27 | -25 | -7 | -1 | 10 | 14 | -2 | -5 | -11 | -21 |
12/2/08 17:27 | 11/20/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | P | 106 | 0.7278 | 0 | 145 | 4 | 3,666 | I | -96 | -93 | -87 | -48 | -29 | -31 | -13 | -2 | -6 | -8 | -17 | 37 | 999 | 999 | |
11/12/08 21:32 | 11/7/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | P | 464 | 0.8291 | 0 | 560 | 19 | 3,521 | I | -93 | -90 | -84 | -40 | -20 | -9 | -6 | -10 | -14 | -23 | -34 | -11 | 999 | 999 | |
9/29/08 19:43 | 9/25/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | P | 623 | 1.04 | 1 | 600 | 12 | 5,619 | I | -88 | -92 | -73 | -72 | -13 | -3 | 12 | 8 | -6 | -5 | -15 | -45 | -6 | 999 | |
9/25/08 17:41 | 9/23/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | P | 79 | 0.9815 | 1 | 80 | 2 | 5,019 | I | -89 | -92 | -75 | -79 | -19 | 0 | 4 | 3 | 7 | -1 | -17 | -39 | -15 | 999 | |
9/24/08 21:01 | 9/22/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | P | 100 | 0.9988 | 1 | 100 | 2 | 4,939 | I | -89 | -93 | -75 | -81 | -21 | -8 | -8 | 2 | -8 | -12 | -21 | -56 | -26 | 999 | |
9/23/08 19:34 | 9/19/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | P | 1,058 | 0.9793 | 1 | 1,081 | 29 | 4,839 | I | -89 | -93 | -72 | -80 | -15 | -12 | -7 | 8 | 9 | 4 | -13 | -43 | -16 | 999 | |
8/22/08 09:03 | 8/20/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Polymeropoulos Mihael Hristos | MD | DO | CEO | P | 57 | 1.13 | 3 | 50 | 17 | 350 | D | -88 | -93 | -77 | -76 | -68 | 10 | -10 | -2 | -2 | -1 | -8 | -38 | -31 | 999 |
8/12/08 10:06 | 8/11/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Polymeropoulos Mihael Hristos | MD | DO | CEO | P | 135 | 1.14 | 4 | 118 | 65 | 300 | D | -87 | -93 | -74 | -74 | -64 | -67 | 19 | 23 | 3 | -6 | -13 | -26 | -39 | 999 |
8/11/08 14:21 | 8/7/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Polymeropoulos Mihael Hristos | MD | DO | CEO | P | 182 | 1.00 | 4 | 182 | New | 182 | D | -88 | -93 | -74 | -76 | -70 | -69 | 19 | 17 | 6 | 8 | -5 | -23 | -32 | 999 |
8/11/08 14:13 | 8/7/08 | VNDA | Health | Drug | Pharmaceutical Preparations | Clark William D | MD | O | SVP,Chie | P | 50 | 0.9900 | 4 | 50 | New | 50 | D | -88 | -93 | -74 | -76 | -70 | -69 | 19 | 17 | 6 | 8 | -5 | -23 | -32 | 999 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |